Drug-Drug Interaction Assessment of WXFL10203614 With Rifampicin, Itraconazole and Metformin: A Three-Cohort Phase I Study.
To evaluate the effects of rifampicin and itraconazole on the pharmacokinetics (PK) of the Janus kinase 1 (JAK1) inhibitor WXFL10203614 and the effects of steady-state WXFL10203614 on metformin PK and safety. In this single-center, open-label, fixed-sequence, self-controlled Phase I study, 54 healthy participants were...